Recombinant multi-species PON3 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis

Genemedi produces recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine PON3 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis.
This gene is a member of the paraoxonase family and lies in a cluster on chromosome 7 with the other two family members. The encoded protein is secreted into the bloodstream and associates with high-density lipoprotein (HDL). The protein also rapidly hydrolyzes lactones and can inhibit the oxidation of low-density lipoprotein (LDL), a function that is believed to slow the initiation and progression of atherosclerosis. Alternatively spliced variants which encode different protein isoforms have been described; however, only one has been fully characterized. [provided by RefSeq, Jul 2008]
The Alternative Names of target: 2810004E20,PON3,Pon3,Serum paraoxonase/lactonase 3

Target products collectionGo to PON3 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)

pdfMSDSpdfCOApdfDatasheet

Product information

Catalog No. Product Name Species Reactivity
GM-Tg-hg-SE0420-Ag-1/ GM-Tg-hg-SE0420-Ag-2 Human PON3 protein Human
GM-Tg-rg-SE0420-Ag-1/ GM-Tg-rg-SE0420-Ag-2 Rat PON3 protein Rat
GM-Tg-mg-SE0420-Ag-1/ GM-Tg-mg-SE0420-Ag-2 Mouse PON3 protein Mouse
GM-Tg-cynog-SE0420-Ag-1/ GM-Tg-cynog-SE0420-Ag-2 Cynomolgus/Rhesus macaque PON3 protein Cynomolgus/ Rhesus macaque
GM-Tg-felg-SE0420-Ag-1/ GM-Tg-felg-SE0420-Ag-2 Feline PON3 protein Feline
GM-Tg-cang-SE0420-Ag-1/ GM-Tg-cang-SE0420-Ag-2 Canine PON3 protein Canine
GM-Tg-bovg-SE0420-Ag-1/ GM-Tg-bovg-SE0420-Ag-2 Bovine PON3 protein Bovine
GM-Tg-equg-SE0420-Ag-1/ GM-Tg-equg-SE0420-Ag-2 Equine PON3 protein Equine

Size： 1mg | 10mg | 100mg



Product Description

Catalog No. GM-Tg-hg-SE0420-Ag-1/ GM-Tg-hg-SE0420-Ag-2; GM-Tg-rg-SE0420-Ag-1/ GM-Tg-rg-SE0420-Ag-2;
GM-Tg-mg-SE0420-Ag-1/ GM-Tg-mg-SE0420-Ag-2; GM-Tg-cynog-SE0420-Ag-1/ GM-Tg-cynog-SE0420-Ag-2;
GM-Tg-felg-SE0420-Ag-1/ GM-Tg-felg-SE0420-Ag-2; GM-Tg-cang-SE0420-Ag-1/ GM-Tg-cang-SE0420-Ag-2;
GM-Tg-bovg-SE0420-Ag-1/ GM-Tg-bovg-SE0420-Ag-2; GM-Tg-equg-SE0420-Ag-1/ GM-Tg-equg-SE0420-Ag-2
Products Name PON3 protein
Species Human, Cynomolgus/ Rhesus macaque, rat, mouse, Feline, Canine, Bovine, Equine
Target Name PON3
Protein Sub-location Secreted Protein/Potential Cytokines
Isotypes Recombinant protein
Expression platform Mammalian cell
Bioactivity validation Affintiy&bioactivity validated by ELISA, cell culture validated.
Tag His
Products description Recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine PON3 protein was expressed in mammalian cell expression system and is expressed with 6 HIS tag at the C-terminus for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic).
Purity Purity: ≥95% (SDS-PAGE)
Application In vitro study, in vivo study, benchmark, positive control for the diagnosis. Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference






    About Gmab

    GDU
    GDU

    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.
    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.